Quick Takeaways
- Singular Genomics Systems, Inc. has 18 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are not currently available.
- Info
- Insider Trading
- Financials
Insider Transactions Reported by 18 Insiders of Singular Genomics Systems, Inc.
- Location
- San Diego, CA
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 09 Apr 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Singular Genomics Systems, Inc. executives and other stock owners filed with the SEC include:
Top shareholders of Singular Genomics Systems, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| James E. Flynn |
3/4/5
13D/G
|
*Possible Member of 10% Group, 10%+ Owner · Deerfield Mgmt IV, L.P. |
100%
from 13D/G
|
9,142,019
mixed-class rows
|
$3,891,028 | — | 01 Jun 2021 | |
| Alexandria Venture Investments, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,645,985
|
$1,120,310 | — | 01 Jun 2021 | |
| Andrew Spaventa |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
22,873
|
$454,944 | — | 21 Feb 2025 | |
| Jorge Velarde |
3/4/5
|
Senior Vice President |
—
class O/S missing
|
340,000
|
$143,956 | — | 26 May 2021 | |
| Sam Ropp |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
167,000
mixed-class rows
|
$138,368 | — | 15 Mar 2024 | |
| Dalen Meeter |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
6,000
|
$120,970 | — | 21 Feb 2025 | |
| Eli N. Glezer |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
6,000
|
$120,970 | — | 21 Feb 2025 | |
| Jyotsna Ghai |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
3,000
|
$60,485 | — | 21 Feb 2025 | |
| Domain Partners IX, L.P. |
13D/G
|
— |
5%
|
125,446
|
$38,888 | $0 | 31 Dec 2024 | |
| Vincent Brancaccio |
3/4/5
|
Vice President, HR |
—
class O/S missing
|
32,500
|
$13,761 | — | 26 May 2021 |
Recent Insider Transactions by Companies or Individuals for Singular Genomics Systems, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* An asterisk sign (*) next to the price indicates that the price is likely invalid.